Over the next two years, IBM’s Watson for Genomics technology will help providers identify precision treatments for 10,000 American veterans with cancer. The public-private collaboration will quicken the pace providers are able to treat patients by mining and analyzing data.
Watson for Genomics will provide physicians with a list of potential therapies ranked by levels of evidence to help them evaluate treatment options.
“Genetic alterations are responsible for most cancers, but it remains challenging for most clinicians to deliver on the promise of precision medicine due to the sheer volume of data surrounding each decision that needs to be made,” said David Shulkin, MD, the VA’s undersecretary for health. “By applying Watson to this problem, we see an opportunity to scale access to precision medicine for America’s veterans.”
More articles on IBM Watson:
IBM Watson partners with 16 health organizations for medical image collaborative
IBM CEO sees ‘no value’ in disclosing Watson’s financial results
IBM Watson sets sights on cybercrime
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
